Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $RPRX vs $VTRS | Chartloom

Compare

$RPRX vs $VTRS

Royalty Pharma PLC · Viatris Inc

RPRX

Royalty Pharma PLC

VTRS

Viatris Inc

Compare $RPRX vs $VTRS

Comparing Royalty Pharma PLC and Viatris Inc

RPRXRoyalty Pharma PLC

VTRSViatris Inc

RPRXRoyalty Pharma PLC

Market cap

$32.57B

P/E (TTM)

38.65x

Forward P/E (NTM)

11.88x

Forward P/S (NTM)

9.72x

Rev growth (TTM)

10.0%

YTD performance

45.6%

52W performance

57.1%

FCF yield

1.8%

VTRSViatris Inc

Market cap

$20.09B

P/E (TTM)

—

Forward P/E (NTM)

6.60x

Forward P/S (NTM)

1.33x

Rev growth (TTM)

4.4%

YTD performance

38.4%

52W performance

77.1%

FCF yield

9.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

RPRX

VTRS

Detailed metrics comparison

RPRX

Royalty Pharma PLC

VTRS

Viatris Inc

Market Cap

RPRX$32.57B

VTRS$20.09B

Enterprise Value

RPRX$40.72B

VTRS$32.55B

Price

RPRX$56.57

VTRS$17.25

P/E Ratio

RPRX38.65x

VTRSN/A

P/S Ratio

RPRX12.84x

VTRS1.36x

EV/Sales

RPRX16.06x

VTRS2.21x

EV/EBITDA

RPRX25.19x

VTRS8.00x

P/B Ratio

RPRX4.79x

VTRS1.42x

P/FCF Ratio

RPRX56.41x

VTRS11.09x

EV/FCF

RPRX70.52x

VTRS17.96x

PEG Ratio

RPRX3.89x

VTRSN/A

Forward P/E (NTM)

RPRX11.88x

VTRS6.60x

Forward P/S (NTM)

RPRX9.72x

VTRS1.33x

Revenue (TTM)

RPRX$2.54B

VTRS$14.74B

Revenue Growth (YoY)

RPRX10.0%

VTRS4.4%

Forward Rev Growth

RPRX5.2%

VTRS2.0%

Gross Margin (TTM)

RPRX0.0%

VTRS40.3%

Operating Margin (TTM)

RPRX59.6%

VTRS0.0%

EBITDA Margin (TTM)

RPRX62.3%

VTRS27.2%

Net Margin (TTM)

RPRX32.1%

VTRS-2.8%

FCF Margin (TTM)

RPRX22.8%

VTRS12.3%

Net Income (TTM)

RPRX$815M

VTRS$-411M

FCF (TTM)

RPRX$578M

VTRS$1.81B

EPS (TTM)

RPRX$1.46

VTRS-$0.35

ROE (TTM)

RPRX12.3%

VTRS-279.0%

ROA (TTM)

RPRX4.2%

VTRS-112.0%

ROIC (TTM)

RPRX5.2%

VTRS-142.0%

Cash

RPRX$812M

VTRS$887M

Debt

RPRX$8.96B

VTRS$13.35B

Net Cash/Debt

RPRX$-8.15B

VTRS$-12.46B

Current Ratio (TTM)

RPRX2.80x

VTRS1.58x

Quick Ratio (TTM)

RPRX2.80x

VTRS0.83x

Debt/Equity (TTM)

RPRX1.31x

VTRS0.94x

Debt/Assets (TTM)

RPRX0.0%

VTRS0.0%

Interest Coverage (TTM)

RPRXN/A

VTRSN/A

Net Debt/EBITDA (TTM)

RPRX0.00x

VTRS0.00x

Beta

RPRX0.39

VTRS0.89

52W Performance

RPRX57.1%

VTRS77.1%

YTD Performance

RPRX45.6%

VTRS38.4%

% from 52W High

RPRX-12.1%

VTRS-6.4%

% from 52W Low

RPRX60.6%

VTRS77.3%

Asset Turnover (TTM)

RPRX0.13x

VTRS0.40x

FCF Yield (TTM)

RPRX1.8%

VTRS9.0%

Earnings Yield (TTM)

RPRX2.5%

VTRS-2.0%

Dividend Yield (TTM)

RPRX1.2%

VTRS2.7%

Rule of 40

RPRX32.8

VTRS16.7

EV/GP/RG

RPRXN/A

VTRS1.97

Ticker research

View RPRX research View VTRS research

Metric	RPRX Royalty Pharma PLC	VTRS Viatris Inc
Market & Valuation
Market Cap	$32.57B	$20.09B
Enterprise Value	$40.72B	$32.55B
Price	$56.57	$17.25
P/E Ratio	38.65x	N/A
P/S Ratio	12.84x	1.36x
EV/Sales	16.06x	2.21x
EV/EBITDA	25.19x	8.00x
P/B Ratio	4.79x	1.42x
P/FCF Ratio	56.41x	11.09x
EV/FCF	70.52x	17.96x
PEG Ratio	3.89x	N/A
Forward P/E (NTM)	11.88x	6.60x
Forward P/S (NTM)	9.72x	1.33x
Revenue & Growth
Revenue (TTM)	$2.54B	$14.74B
Revenue Growth (YoY)	10.0%	4.4%
Forward Rev Growth	5.2%	2.0%
Profitability
Gross Margin (TTM)	0.0%	40.3%
Operating Margin (TTM)	59.6%	0.0%
EBITDA Margin (TTM)	62.3%	27.2%
Net Margin (TTM)	32.1%	-2.8%
FCF Margin (TTM)	22.8%	12.3%
Net Income (TTM)	$815M	$-411M
FCF (TTM)	$578M	$1.81B
EPS (TTM)	$1.46	-$0.35
ROE (TTM)	12.3%	-279.0%
ROA (TTM)	4.2%	-112.0%
ROIC (TTM)	5.2%	-142.0%
Financial Health
Cash	$812M	$887M
Debt	$8.96B	$13.35B
Net Cash/Debt	$-8.15B	$-12.46B
Current Ratio (TTM)	2.80x	1.58x
Quick Ratio (TTM)	2.80x	0.83x
Debt/Equity (TTM)	1.31x	0.94x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.39	0.89
52W Performance	57.1%	77.1%
YTD Performance	45.6%	38.4%
% from 52W High	-12.1%	-6.4%
% from 52W Low	60.6%	77.3%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.40x
FCF Yield (TTM)	1.8%	9.0%
Earnings Yield (TTM)	2.5%	-2.0%
Dividend Yield (TTM)	1.2%	2.7%
Other
Rule of 40	32.8	16.7
EV/GP/RG	N/A	1.97
Ticker research	View RPRX research	View VTRS research

Valuation

P/E Ratio

RPRX

38.65x

P/S Ratio

VTRS

1.36x

RPRX

12.84x

EV/FCF

VTRS

17.96x

RPRX

70.52x

Growth & revenue

Revenue Growth TTM

RPRX

10.0%

VTRS

4.4%

Forward Revenue Growth

RPRX

5.2%

VTRS

2.0%

Profitability & performance

Gross Margin

VTRS

40.3%

RPRX

0.0%

ROE

RPRX

12.3%

VTRS

-279.0%

FCF Yield %

VTRS

9.0%

RPRX

1.8%

52-Week Performance

VTRS

77.1%

RPRX

57.1%

Detailed metrics comparison

RPRX

Royalty Pharma PLC

VTRS

Viatris Inc

Market Cap

RPRX$32.57B

VTRS$20.09B

Enterprise Value

RPRX$40.72B

VTRS$32.55B

Price

RPRX$56.57

VTRS$17.25

P/E Ratio

RPRX38.65x

VTRSN/A

P/S Ratio

RPRX12.84x

VTRS1.36x

EV/Sales

RPRX16.06x

VTRS2.21x

EV/EBITDA

RPRX25.19x

VTRS8.00x

P/B Ratio

RPRX4.79x

VTRS1.42x

P/FCF Ratio

RPRX56.41x

VTRS11.09x

EV/FCF

RPRX70.52x

VTRS17.96x

PEG Ratio

RPRX3.89x

VTRSN/A

Forward P/E (NTM)

RPRX11.88x

VTRS6.60x

Forward P/S (NTM)

RPRX9.72x

VTRS1.33x

Revenue (TTM)

RPRX$2.54B

VTRS$14.74B

Revenue Growth (YoY)

RPRX10.0%

VTRS4.4%

Forward Rev Growth

RPRX5.2%

VTRS2.0%

Gross Margin (TTM)

RPRX0.0%

VTRS40.3%

Operating Margin (TTM)

RPRX59.6%

VTRS0.0%

EBITDA Margin (TTM)

RPRX62.3%

VTRS27.2%

Net Margin (TTM)

RPRX32.1%

VTRS-2.8%

FCF Margin (TTM)

RPRX22.8%

VTRS12.3%

Net Income (TTM)

RPRX$815M

VTRS$-411M

FCF (TTM)

RPRX$578M

VTRS$1.81B

EPS (TTM)

RPRX$1.46

VTRS-$0.35

ROE (TTM)

RPRX12.3%

VTRS-279.0%

ROA (TTM)

RPRX4.2%

VTRS-112.0%

ROIC (TTM)

RPRX5.2%

VTRS-142.0%

Cash

RPRX$812M

VTRS$887M

Debt

RPRX$8.96B

VTRS$13.35B

Net Cash/Debt

RPRX$-8.15B

VTRS$-12.46B

Current Ratio (TTM)

RPRX2.80x

VTRS1.58x

Quick Ratio (TTM)

RPRX2.80x

VTRS0.83x

Debt/Equity (TTM)

RPRX1.31x

VTRS0.94x

Debt/Assets (TTM)

RPRX0.0%

VTRS0.0%

Interest Coverage (TTM)

RPRXN/A

VTRSN/A

Net Debt/EBITDA (TTM)

RPRX0.00x

VTRS0.00x

Beta

RPRX0.39

VTRS0.89

52W Performance

RPRX57.1%

VTRS77.1%

YTD Performance

RPRX45.6%

VTRS38.4%

% from 52W High

RPRX-12.1%

VTRS-6.4%

% from 52W Low

RPRX60.6%

VTRS77.3%

Asset Turnover (TTM)

RPRX0.13x

VTRS0.40x

FCF Yield (TTM)

RPRX1.8%

VTRS9.0%

Earnings Yield (TTM)

RPRX2.5%

VTRS-2.0%

Dividend Yield (TTM)

RPRX1.2%

VTRS2.7%

Rule of 40

RPRX32.8

VTRS16.7

EV/GP/RG

RPRXN/A

VTRS1.97

Ticker research

View RPRX research View VTRS research

Metric	RPRX Royalty Pharma PLC	VTRS Viatris Inc
Market & Valuation
Market Cap	$32.57B	$20.09B
Enterprise Value	$40.72B	$32.55B
Price	$56.57	$17.25
P/E Ratio	38.65x	N/A
P/S Ratio	12.84x	1.36x
EV/Sales	16.06x	2.21x
EV/EBITDA	25.19x	8.00x
P/B Ratio	4.79x	1.42x
P/FCF Ratio	56.41x	11.09x
EV/FCF	70.52x	17.96x
PEG Ratio	3.89x	N/A
Forward P/E (NTM)	11.88x	6.60x
Forward P/S (NTM)	9.72x	1.33x
Revenue & Growth
Revenue (TTM)	$2.54B	$14.74B
Revenue Growth (YoY)	10.0%	4.4%
Forward Rev Growth	5.2%	2.0%
Profitability
Gross Margin (TTM)	0.0%	40.3%
Operating Margin (TTM)	59.6%	0.0%
EBITDA Margin (TTM)	62.3%	27.2%
Net Margin (TTM)	32.1%	-2.8%
FCF Margin (TTM)	22.8%	12.3%
Net Income (TTM)	$815M	$-411M
FCF (TTM)	$578M	$1.81B
EPS (TTM)	$1.46	-$0.35
ROE (TTM)	12.3%	-279.0%
ROA (TTM)	4.2%	-112.0%
ROIC (TTM)	5.2%	-142.0%
Financial Health
Cash	$812M	$887M
Debt	$8.96B	$13.35B
Net Cash/Debt	$-8.15B	$-12.46B
Current Ratio (TTM)	2.80x	1.58x
Quick Ratio (TTM)	2.80x	0.83x
Debt/Equity (TTM)	1.31x	0.94x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.39	0.89
52W Performance	57.1%	77.1%
YTD Performance	45.6%	38.4%
% from 52W High	-12.1%	-6.4%
% from 52W Low	60.6%	77.3%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.40x
FCF Yield (TTM)	1.8%	9.0%
Earnings Yield (TTM)	2.5%	-2.0%
Dividend Yield (TTM)	1.2%	2.7%
Other
Rule of 40	32.8	16.7
EV/GP/RG	N/A	1.97
Ticker research	View RPRX research	View VTRS research